Objectives: The aim of this study was to detect and characterize plasmid-mediated quinolone resistance determinants as well as genes responsible for additional resistances in Enterobacteriaceae isolates in Spain.
Introduction
Fluoroquinolones are antimicrobials that are commonly used in clinical or veterinary medicine. Their common mechanism, whereby they act as a cellular poison by binding the target enzyme -DNA complexes after strand breakage and before resealing of DNA, means that resistance to one fluoroquinolone will confer resistance to all fluoroquinolones. Quinolone resistance in Enterobacteriaceae usually originates from mutations in target enzymes (DNA gyrase and/or topoisomerase IV) or because of impaired access to the target, occurring either because of changes in porin expression or because of overexpression of efflux pumps. 1 Recently, plasmid-mediated quinolone resistance (PMQR) has been detected conferring low-level resistance to quinolones by different mechanisms: a modifying enzyme [AAC(6 ′ )-Ib-cr]; the QepA and OqxAB efflux pumps; or gyrase and topoisomerase IV protection proteins (Qnr). A unique allele has been described for the aac(6 ′ )-Ib-cr and oqxAB genes, two alleles have been described for qepA and several qnr genes, named qnrB, qnrS, qnrC and qnrD, have been described in various Gram-negative bacterial species since the first description of qnrA.
2 To date, 7 variants of QnrA (QnrA1 to QnrA7), 25 variants of QnrB (QnrB1 to QnrB25), 1 variant of QnrC, 4 variants of QnrS (QnrS1 to QnrS4) and 1 variant of QnrD are known (http://www. lahey.org/qnrStudies). Although currently qnr-positive strains are relatively infrequent, widespread horizontal transfer among strains could contribute to the eventual compromise of the use of fluoroquinolones. Besides, qnr-positive strains in the absence of other resistance mechanisms are susceptible to fluoroquinolones according to the CLSI breakpoints, making their detection difficult. Although the clinical relevance of PMQR is unclear, linkage of PMQR to b-lactamases on plasmids has been described to contribute to the dissemination of extended-spectrum b-lactamase (ESBL) producers with reduced susceptibility to quinolones through co-selection. The aim of this study was to detect and characterize PMQR determinants as well as genes responsible for additional resistances in Enterobacteriaceae isolates in Spain.
Materials and methods

Bacterial isolates and susceptibility tests
As a routine, a third of the isolates submitted to the Spanish Reference Laboratory for Salmonella (SRLS) are screened for resistance. Susceptibility to antimicrobials was tested by the disc diffusion method according to CLSI guidelines. The original panel included the following antimicrobials: ampicillin; cefalotin; cefotaxime; amoxicillin/clavulanic acid; tetracycline; streptomycin; kanamycin; gentamicin; nalidixic acid; ciprofloxacin; chloramphenicol; trimethoprim/sulfamethoxazole; and a sulphonamide compound (sulfadiazine, sulfathiazole and sulfamerazine sodium). A synergy test was performed for all isolates with amoxicillin/ clavulanic acid and cefotaxime discs placed 30 mm apart. The MICs of nalidixic acid and ciprofloxacin were determined by Etests for isolates susceptible to nalidixic acid but showing a decrease in the diameter of the inhibition halo of ciprofloxacin (≤27 mm). Results were interpreted according to the CLSI guidelines. Escherichia coli ATCC 25922 was used as a control strain.
The XbaI-PFGE patterns of strains were compared according to the PulseNet-Europe protocol (http://www.pulsenet-europe.org/docs.htm).
Characterization of resistances
PCR and sequencing of PMQR determinants [qnr, aac(6 ′ )-Ib-cr and qepA genes] and the study of the quinolone resistance-determining regions (QRDRs) of gyrA and parC genes were performed as previously described. 3, 4 Detection and identification of b-lactamases and additional resistance genes were performed for the PMQR-positive isolates as previously described. Class I integrons were analysed by PCR and sequencing on both strands.
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Plasmid characterization and localization of qnr genes
Transfer of resistance was tested by conjugation experiments using a rifampicin-resistant E. coli as recipient and all Qnr-producing strains as donors and rifampicin (50 mg/L) and ampicillin/streptomycin (100 mg/ L) to select transconjugants. 6 The presence of plasmids and plasmid sizes were assessed by S1-PFGE or plasmid extraction following the QIAprep Spin Miniprep Kit instructions (Qiagen) from every parental and transconjugant strain, if any. Incompatibility groups were assigned by PCR-based replicon typing. 4 The localization of qnr and b-lactamase genes was determined by Southern blot hybridization using PCR-generated digoxigenin-labelled probes. 6 
Results and discussion
In total, 19010 isolates (18 624 Salmonella spp., 285 E. coli, 68 Shigella spp., 29 Klebsiella pneumoniae, 2 Citrobacter freundii and 2 Proteus mirabilis) were tested between 2003 and 2008. Thirty-seven strains exhibited an unusual quinolone resistance phenotype, having decreased susceptibility to ciprofloxacin (MIC 0.12-0.5 mg/L) but still susceptible to nalidixic acid (MIC 8 -16 mg/L). These values have been previously proposed to identify qnr-positive strains. Because of the predominance of Salmonella Thompson (n¼ 6) and Salmonella Typhimurium DT104b (n¼ 24) among these strains, we extended the study to all the strains with these sero-phagetypes in our collection. Thus, 19 additional Salmonella Thompson and 67 Salmonella Typhimurium DT104b strains exhibited a quinolone resistance phenotype compatible with the presence of qnr. Therefore, a total of 123 strains from the SRLS collection were included in the study. Amplification and sequencing of aac(6 ′ )-Ib-cr, qepA and qnr genes, and analysis of the mutations in the QRDRs of gyrA and parC genes, revealed qnr genes as the only determinant responsible for the quinolone phenotype ( Table 1 ). All of the positive strains were isolated from sporadic cases in humans, except for nine Salmonella Typhimurium DT104b strains, which were isolated from bathing areas (n¼ 3) and aquarium water (n¼ 6).
Many surveys have shown that Qnr-positive Enterobacteriaceae express plasmid-encoded b-lactamases, especially for QnrA-and QnrB-producing isolates. 2 In this study 4 out of 123 qnr-positive isolates expressed an ESBL or AmpC enzyme (Table 1) .
Only six transconjugants were obtained. Plasmid analysis showed that qnrB2 was transferred with bla SHV-12 on an IncHI2 plasmid of 320 kb. Resistances to streptomycin, tetracycline, chloramphenicol and the sulphonamide compound were co-transferred. qnrB4 was transferred with bla DHA-1 on an IncFIIs plasmid of 70 kb. IncHI2 plasmids associated with qnrB2 and bla SHV-12 have already been described in Salmonella Bredeney in Spain and in Salmonella Senftenberg in the Netherlands. 8 However, although the association of qnrB4 and bla DHA-1 is very common in K. pneumoniae, 9 to the best of our knowledge this is the first description of such an association in Salmonella and the first description of a qnrB4 gene on an IncFIIs plasmid. qnrA1 was transferred with bla CTX-M-9 in E. coli on an IncHI2 plasmid of 220 kb. Resistances to the sulphonamide compound, trimethoprim/sulfamethoxazole and chloramphenicol were co-transferred. The association of qnrA1 and bla CTX-M-9 has been reported in E. coli, but no reference to the incompatibility group of the plasmid was made. 10 One transconjugant from Salmonella Typhimurium harbouring bla SHV-12 was obtained, but only an IncHI2 plasmid of 95 kb carrying the b-lactamase gene was transferred. IncHI2 plasmids harbouring bla CTX-M-9 genes are very common in Spain in both E. coli and Salmonella. E. coli strains harbouring qnrA1, bla CTX-M-9 and bla SHV-12 have been reported in Spain. 11 Finally, two transconjugants from Salmonella Thompson harbouring qnrA1 also harboured an IncHI2 plasmid of 220 kb. In these cases, resistances to ampicillin, amoxicillin/clavulanic acid and the sulphonamide compound were co-transferred. Hybridization assays revealed the presence of the qnr gene on the plasmid. This is the first description of a qnrA1 gene on an IncHI2 plasmid in Salmonella Thompson, although qnrA1 has been described in a 250-340 kb IncHI2 non-conjugative plasmid in Salmonella Concord in Spain. 12 Considering the strains that were negative with regard to conjugation assays, most of the Salmonella Thompson strains harboured a large non-typeable plasmid, although one strain carried an IncA/C plasmid, and as far as we know this is the first report of a qnrA1 gene on an IncA/C plasmid in Salmonella. The qnrS1 gene was detected mostly on a ColE Tp plasmid of 10 kb (Table 1) . qnrS1 has been widely described in Salmonella and the same plasmid identified here has been completely sequenced from Salmonella Typhimurium DT193. 13 Comparison of PFGE patterns of all Salmonella Thompson strains suggested that they were clonally related (.92.5% similarity), with the exception of the isolate with the 120 kb plasmid (80.9% similarity). PFGE analysis of Salmonella Typhimurium DT104b strains suggested clonal relatedness (.83.6% similarity) with the exception of the two isolates with the larger plasmid (79.1%), which shared an identical PFGE profile.
In Spain, some variants of qnr genes have been described in Enterobacteriaceae: qnrA1 in K. pneumoniae, Enterobacter cloacae, C. freundii and E. coli; qnrB-like, qnrB6 and qnrB16 in E. coli and Citrobacter spp.; and qnrS1 in Enterobacter spp. and K. pneumoniae. 2, 14, 15 This is the first epidemiological study of qnr genes in Spain 289 JAC qnr genes in Enterobacteriaceae isolates from Spain. The Salmonella plasmids bearing these genes were not a localized phenomenon. We identified these resistance determinants in five serotypes distributed across Spain. Regarding the temporal distribution of the qnr-positive serotypes most commonly identified, Salmonella Typhimurium DT104b appeared throughout all the years of the study while Salmonella Thompson appeared in the last 3 years. The presence of qnrA1 in Salmonella Thompson and qnrS1 in Salmonella Typhimurium with a high genetic similarity by PFGE (one and three bands difference, respectively), suggests that two clonal groups appeared and have persisted, increased and evolved over the years. Although their clinical implications are still unknown, the spread of PMQR in Salmonella serotypes commonly implicated in human infections in Spain is concerning since there have been reported failures in the treatment with fluoroquinolones of patients infected with Salmonella with decreased susceptibility to this compound. 16 Furthermore, they often co-exist with other resistances (98% of the isolates showed resistance to other antimicrobial agents) and sometimes are co-transferred, enabling the propagation of resistance to antimicrobial agents commonly used to treat serious Salmonella infections, in the case of ESBLs, and co-selection by the use of either agent alone. Salmonellosis is a zoonotic disease. Therefore, vigilant surveillance and prospective studies (together with the proper use of antimicrobial agents in human and veterinary medicine) are necessary to determine changes in prevalence, and the basis for the appearance and co-selection of resistances, in order to limit the spread of PMQR.
